SREBPs regulate fatty acid and cholesterol metabolism [10], and their targets genes, such as fatty acid synthase (FASN) and stearoyl-CoA desaturase-1 (SCD1), are therapeutic targets in many cancers [36, 37]. The gene discussed is FASN; the disease is cancer.